HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Botta Selected Research

monoethylglycinexylidide (L 86)

1/2003MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.
12/2001Impairment of cytochrome P-450-dependent liver activity in cirrhotic patients with Helicobacter pylori infection.
8/2000Histologic determinants of monoethylglycinexylidide formation in patients with chronic hepatitis C.
8/2000The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosis.
7/2000Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis.
1/200013CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Botta Research Topics

Disease

6Fibrosis (Cirrhosis)
06/2003 - 01/2000
6Chronic Hepatitis C
11/2001 - 06/2000
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2003 - 01/2000
4Infections
12/2001 - 10/2000
4Chronic Hepatitis (Chronic Active Hepatitis)
08/2000 - 01/2000
3Hepatocellular Carcinoma (Hepatoma)
09/2019 - 07/2000
3Liver Neoplasms (Liver Cancer)
03/2004 - 07/2000
3Liver Diseases (Liver Disease)
08/2000 - 07/2000
2Breast Neoplasms (Breast Cancer)
01/2020 - 01/2010
2Neoplasms (Cancer)
04/2011 - 09/2000
1Hypertension (High Blood Pressure)
01/2013
1Triple Negative Breast Neoplasms
01/2012
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2009
1End Stage Liver Disease
06/2003
1Ascites
01/2003
1Iron Overload
11/2001
1Disease Progression
04/2001
1Viremia
11/2000
1Hepatic Encephalopathy
08/2000
1Cholestasis
07/2000

Drug/Important Bio-Agent (IBA)

6monoethylglycinexylidide (L 86)IBA
01/2003 - 01/2000
3Glutathione Transferase (Glutathione S-Transferase)IBA
11/2001 - 06/2000
3RNA (Ribonucleic Acid)IBA
03/2001 - 06/2000
2Radioisotopes (Radionuclides)IBA
04/2011 - 01/2010
2LeptinIBA
11/2000 - 07/2000
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
09/2000 - 07/2000
1Edotreotide (SMT 487)IBA
01/2013
1Peptides (Polypeptides)IBA
04/2011
1Biological ProductsIBA
04/2011
1Somatostatin Receptors (Somatostatin Receptor)IBA
04/2011
1Peptide Receptors (Peptide Receptor)IBA
04/2011
1ibritumomab tiuxetan (Zevalin)FDA Link
11/2009
1CreatinineIBA
01/2003
1CytokinesIBA
12/2001
1CytochromesIBA
12/2001
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
12/2001
1Ferritins (Ferritin)IBA
11/2001
1IronIBA
11/2001
1InterferonsIBA
04/2001
1Interferon-alpha (Interferon Alfa)IBA
04/2001
1Bile Acids and Salts (Bile Acids)IBA
03/2001
1Pharmaceutical PreparationsIBA
10/2000
1Lidocaine (Xylocaine)FDA LinkGeneric
08/2000
1Alkaline PhosphataseIBA
07/2000
1Alanine Transaminase (SGPT)IBA
06/2000
1glutathione S-transferase alphaIBA
06/2000
1Transaminases (Aminotransferases)IBA
06/2000
1Aminopyrine (Aminophenazone)IBA
01/2000

Therapy/Procedure

4Therapeutics
01/2012 - 04/2001
2Surgical Instruments (Clip)
03/2004 - 06/2003
1Mammaplasty (Breast Reconstruction)
01/2020
1Radiofrequency Ablation
09/2019
1Segmental Mastectomy (Lumpectomy)
01/2010
1Radiotherapy
01/2010
1Palliative Care (Palliative Therapy)
06/2003
1Aftercare (After-Treatment)
06/2003
1Catheters
06/2003
1Liver Transplantation
01/2003
1Polypharmacy
10/2000